Avricore Health Inc. (TSXV:AVCR)
0.0550
0.00 (0.00%)
Aug 10, 2026, 1:36 PM EST
Avricore Health Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.2 | 0.23 | 1.13 | 0.28 | 0.62 | 2.01 |
Short-Term Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - |
Cash & Short-Term Investments | 0.21 | 0.24 | 1.14 | 0.29 | 0.63 | 2.01 |
Cash Growth | -83.57% | -79.17% | 298.64% | -54.55% | -68.68% | 564.98% |
Accounts Receivable | 0.05 | 0.04 | 0.42 | 0.43 | 0.77 | 0.09 |
Inventory | 0.04 | - | 0 | 0.02 | - | - |
Other Current Assets | 0.1 | 0.09 | 0.02 | 0.04 | 0.03 | 0.05 |
Total Current Assets | 0.4 | 0.37 | 1.58 | 0.77 | 1.43 | 2.16 |
Net Property, Plant & Equipment | 0.18 | 0.2 | 0.66 | 1.72 | 1.11 | 0.09 |
Other Intangible Assets | 0 | 0 | 0.06 | 0.05 | 0.03 | 0.03 |
Total Assets | 0.58 | 0.56 | 2.3 | 2.54 | 2.57 | 2.28 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.39 | 0.17 | 0.33 | 0.49 | 0.31 | 0.04 |
Current Portion of Long-Term Debt | - | - | - | 0.04 | 0.04 | 0.04 |
Unearned Revenue | - | - | - | - | 0.25 | - |
Total Current Liabilities | 0.39 | 0.17 | 0.33 | 0.53 | 0.6 | 0.08 |
Total Liabilities | 0.39 | 0.17 | 0.33 | 0.53 | 0.6 | 0.08 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 27.3 | 27.3 | 27.3 | 27.19 | 27.06 | 26.62 |
Additional Paid-in Capital | 7.36 | 7.35 | 7.07 | 6.56 | 5.93 | 5.79 |
Accumulated Other Comprehensive Income | 0 | -0 | -0 | - | - | - |
Retained Earnings | -34.47 | -34.26 | -32.4 | -31.74 | -31.03 | -30.22 |
Shareholders' Equity | 0.2 | 0.39 | 1.97 | 2.01 | 1.96 | 2.2 |
Total Liabilities & Equity | 0.58 | 0.56 | 2.3 | 2.54 | 2.57 | 2.28 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0 | 0 | 0.04 | 0.04 | 0.04 |
Net Cash (Debt) | 0.21 | 0.24 | 1.14 | 0.25 | 0.59 | 1.97 |
Net Cash Growth | -83.57% | -79.17% | 363.31% | -58.25% | -70.07% | - |
Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.02 |
Book Value | 0.2 | 0.39 | 1.97 | 2.01 | 1.96 | 2.2 |
Book Value Per Share | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |
Tangible Book Value | 0.2 | 0.39 | 1.91 | 1.96 | 1.93 | 2.17 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |